Fundraising FoxArtis Ventures — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
BiotechSan Francisco, US
Daniel Dornbusch(Executive Officer, Director)
BoardAshok Krishnamurthi(Director)inWilliam Carson(Director)
Board seatVasudev Bailey· per SEC Form D
Co-investorsAlumni VenturesAnzu PartnersCota CapitalGaingelsOlive Tree CapitalAdjuvant Capital+1 more
__Twitter.png)
HealthtechWest Palm Beach, US
Randy Beckham(Executive Officer)Eric R. Hanson(Executive Officer, Director)Charles Middleton(Executive Officer)Edward Hammel(Executive Officer)Michael Josephs(Executive Officer)David Saloff(Executive Officer, Director)in
Board seatStuart Peterson· per SEC Form D
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)
Co-investorsBailey Venture PartnersCasa Verde CapitalDolby Family VenturesGaingelsIaso VenturesNoetic+9 more
Seed develops clinically studied probiotic and prebiotic formulations designed to support digestive health and overall wellness through proprietary delivery technology that protects beneficial bacteria through the digestive tract.
HealthtechWellness & FitnessVenice, US
Ara Katz(Executive Officer, Director)inRajat Dhir(Executive Officer, Director)Andy Bradley(Executive Officer)
Co-investorsAlumni VenturesBold Capital PartnersBoxGroupCollaborative FundColor CapitalCota Capital+16 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.